Short-course radiation before surgery for stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests if giving a short course of radiation before surgery, along with standard chemotherapy, can help treat stomach cancer. It is for people newly diagnosed with stomach cancer who have not had treatment before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have newly diagnosed stomach cancer that started in the stomach (though it may reach the esophagus slightly).
- You must be at least 18 years old and healthy enough for daily activities (ECOG score 0, 1, or 2).
- You must have had scans (CT or PET/CT) to check the size and spread of the cancer.
- Your blood counts and kidney function must meet certain minimum levels.
- You cannot have had any prior surgery, radiation, or chemotherapy for stomach or esophageal cancer.
- If you are able to become pregnant, you must agree to use effective birth control during and for a time after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach for stomach cancer that has spread to nearby tissues but not to other organs. You would get a short course of radiation, followed by a combination of targeted therapy (Disitamab Vedotin), chemotherapy (S-1), and immunotherapy (Sintilimab) before surgery to shrink the tumor and improve outcomes.
This study tests combining an immunotherapy drug (PD-1 inhibitor) and a medication to boost your immune system (thymalfasin) with standard chemotherapy and radiation before surgery for stage III cancer where the stomach meets the esophagus. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests combining chemotherapy (SOX), an immunotherapy drug (tislelizumab), and low-dose radiation before surgery for people with locally advanced stomach or gastroesophageal junction cancer. The goal is to see if this combination shrinks tumors more effectively.
This trial tests a combination of four chemotherapy drugs (irinotecan liposome, 5-FU + leucovorin, oxaliplatin, and Karelizumab) given before surgery to shrink stomach cancer. The goal is to see if this combination makes the cancer easier to remove and improves outcomes.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.